发明名称 VERFAHREN UND ZUSAMMENSETZUNGEN ZUR VERABREICHUNG VON LIPOPHILEN HEILMITTELN IN EINER DOSIERUNG NACH DER GEWÜNSCHTEN WIRKUNG
摘要 The present invention is directed to methods and compositions for noninvasively administering lipophilic drugs in a dose-to-effect manner to produce antimigraine, oxytoxic, antiemetic, hypoglycemic, anti-Parkinsonian, antidiuretic, antifungal, antisecretory, or bronchodilator activity. A patient is put at ease when given the lollipop, and the lipophilic drug rapidly enters the patient's bloodstream as the lollipop is sucked. When treating the patient, the physician can observe the patient's condition and terminate the use of the lollipop when it has had a desired effect on the patient. The drug-containing lollipop can be self-administered by the patient in response to subjective symptoms and to the patient's susceptibility to the lipophilic drug.
申请公布号 DE68928415(T2) 申请公布日期 1998.02.26
申请号 DE1989628415T 申请日期 1989.09.05
申请人 UNIVERSITY OF UTAH RESEARCH INSTITUTE, SALT LAKE CITY, UTAH, US 发明人 STANLEY, THEODORE, H., SALT LAKE CITY, UT 84124, US;HAGUE, BRIAN, WEST VALLEY CITY, UT 84119, US
分类号 A61K9/00;A61K9/20;A61K31/135;A61K31/165;A61K31/415;A61K31/445;A61K31/47;A61K31/475;A61K31/48;A61K31/495;A61K31/52;A61K33/06;A61K38/11;A61K38/28;A61P1/00;A61P1/08;A61P3/08;A61P7/12;A61P11/00;A61P13/02;A61P15/00;A61P25/02;A61P25/04;A61P31/04 主分类号 A61K9/00
代理机构 代理人
主权项
地址